Activation of NF-κB pathway in Duchenne muscular dystrophy: Relation to age

Acta Myologica

Volumn 30, Issue JUNE, 2011, Pages 16-23

  Messina, S ^a   Vita, Gian Luca ^a   Aguennouz, M ^a   Sframeli, M ^a   Romeo, S ^a   Rodolico, C ^a   Vita, G ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

DMD; NF B; TNF

Indexed keywords

GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MUSCLE NECROSIS; MUSCLE REGENERATION; PRESCHOOL CHILD; SCHOOL CHILD; UPREGULATION; AGING; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; METABOLISM; NECROSIS; PATHOLOGY; REGENERATION; SKELETAL MUSCLE;

AGING; ANTIOXIDANTS; CHILD; CHILD, PRESCHOOL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTATHIONE PEROXIDASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; NECROSIS; NF-KAPPA B; REGENERATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79958072264     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem 1999;274:27339-42.
2. Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signaling. Semin Immunol 2000;12:85-98. (Pubitemid 30114019)
3. Baldwin Jr AS. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 2001;107:3-6.
4. Zhou LZ, Johnson AP, Rando TA. NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic Biol Med 2001;31:1405-16. (Pubitemid 33145310)
5. Dubowitz V. Muscle Disorders in Childhood. 2nd edition. Philadelphia, Pennsylvania, USA: WB Saunders Company Ltd 1995.
6. Emery EH. The muscular dystrophies. Lancet 2002;359:687-95.
7. Grounds MD, Torrisi J. Anti-TNF-α (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J 2004;18:668-82.
8. Tidball JG: Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 2005;288:345-53.
9. Hodgetts S, Radley H, Davies M, et al. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice. Neuromuscul Disord 2006;16:591-602. (Pubitemid 44374323)
10. Evans NP, Misyak SA, Robertson JL, et al. Immune mediated mechanisms potentially regulate the disease time course of Duchenne muscular dystrophy and provide targets for therapeutic intervention. J Phys Med Rehabil 2009;1:755-68.
11. Murphy ME, Kehrer JP. Oxidative stress and muscular dystrophy. Chem Biol Interact 1989;69:101-78.
12. Monici MC, Aguennouz M, Mazzeo A, et al. Activation of nuclear factor-kB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 2003;60:993-7. (Pubitemid 36348934)
13. Kumar A, Boriek AM. Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J 2003;17:386-96. (Pubitemid 36292954)
14. Messina S, Altavilla D, Aguennouz M, et al. Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am J Pathol 2006;168:918-26. (Pubitemid 43327744)
15. Messina S, Bitto A, Aguennouz M, et al. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Exp Neurol 2006;198:234-41. (Pubitemid 43243761)
16. Messina S, Bitto A, Aguennouz M, et al. Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone. Exp Neurol 2009; 220:349-58.
17. Acharyya S, Villalta S, Bakkar N, et al. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 2007;117:889-901. (Pubitemid 46556745)
18. Acharyya S, Sharma SM, Cheng AS, et al. TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in Duchenne muscular dystrophy. PLoS One 2010;5:e12479.
19. Spence HJ, Yun-Ju C, Steven JW. Muscular dystrophies, the cytoskeleton and cell adhesion. Bioessays 2002; 24:542-52. (Pubitemid 34629874)
20. Pasternak C, Wong S, Elson EL Mechanical function of dystrophin in muscle cells. J Cell Biol 1995;128:355-61.
21. Petrof BJ, Shrager JB, Stedman HH, et al. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. PNAS 1993;90:3710-4. (Pubitemid 23111437)
22. Kumar A, Khandelwal N, Malya R, et al. Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. FASEB J 2004;18:102-13. (Pubitemid 38076470)
23. Porter JD, Guo W, Merriam AP, et al. Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle. Neuromuscul Disord 2003;13:223-35. (Pubitemid 36279427)
24. Mourkioti F, Kratsios P, Luedde T, et al. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J Clin Invest 2006;116:2945-54. (Pubitemid 44684479)
25. Evans NP, Misyak SA, Robertson JL, et al. Dysregulated intracellular signaling and inflammatory gene expression during initial disease onset in Duchenne muscular dystrophy. Am J Phys Med Rehabil 2009;88:502-22.
26. Dubowitz V, Sewry C. Muscle biopsy: a practical approach. AUTHOR PLEASE INDICATE CITY OF PUBLISHER: Saunders Elsevier 2007.
27. Arahata K, Engel A. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984;16:193-208.
28. Engel A, Arahata K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986;17:704-21. (Pubitemid 16070409)
29. Gorospe J, Tharp M, Hinckley J, et al. A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice. J Neurol Sci 1994;122:44-56. (Pubitemid 24073749)
30. Hnia K, Gayraud J, Hugon G, et al. L-arginine decreases inflammation and modulates the nuclear factorkappaB/matrix metalloproteinase cascade in mdx muscle fibers. Am J Pathos 2008;172:1509-19. (Pubitemid 351793345)
31. Collins RA, Grounds MD. The role of tumor necrosis factor-alpha (TNF-alpha) in skeletal muscle regeneration. Studies in TNF-alpha(-/-) and TNF-alpha(-/-)/LT-alpha(-/-) mice. J Histochem Cytochem 2001;49:989-1001. (Pubitemid 32675006)
32. Guzik TJ, D Mangalat, R. Korbut: Adipocytokines-novel link between inflammation and vascular function? J. Physiol Pharmacol 2006;57:505-28. (Pubitemid 46096102)
33. Hauner H. The new concept of adipose tissue function. Physiol Behav 2004;83:653-8. (Pubitemid 40038516)
34. Tidball JG, Wehling-Henricks M. The role of free radicals in the pathophysiology of muscular dystrophy. J Appl Physiol 2007;102:1677-86. (Pubitemid 46571068)